1. Home
  2. ARDX vs UPBD Comparison

ARDX vs UPBD Comparison

Compare ARDX & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$4.05

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Upbound Group Inc.

UPBD

Upbound Group Inc.

HOLD

Current Price

$19.81

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
UPBD
Founded
2007
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
ARDX
UPBD
Price
$4.05
$19.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
$15.14
$32.25
AVG Volume (30 Days)
2.6M
1.1M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
8.25%
EPS Growth
N/A
N/A
EPS
N/A
0.98
Revenue
$2,607,000.00
$4,695,061,000.00
Revenue This Year
$37.75
$5.96
Revenue Next Year
$34.24
$6.47
P/E Ratio
N/A
$20.07
Revenue Growth
N/A
8.67
52 Week Low
$4.71
$15.82
52 Week High
$8.40
$28.03

Technical Indicators

Market Signals
Indicator
ARDX
UPBD
Relative Strength Index (RSI) 34.44 44.15
Support Level N/A $16.88
Resistance Level $6.47 $19.75
Average True Range (ATR) 0.16 0.85
MACD 0.01 -0.24
Stochastic Oscillator 12.09 22.16

Price Performance

Historical Comparison
ARDX
UPBD

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions, Mexico segment offers lease-to-own stores in Mexico. The The Brigit segment offers various financial health products and tools to help users improve their financial health. The company derives a majority of its revenue from the Acima segment.

Share on Social Networks: